“TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK”. 2025. TRAKIA JOURNAL OF SCIENCES 23 (Supplement 1): 6. https://doi.org/10.15547/tjs.2025.s.01.004.